Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes
Amit S. Kalgutkar, Heather L. Hatch, Frederick Kosea, Hang T. Nguyen, Edna F. Choo, Kim F. McClure, Timothy J. Taylor, Kirk R. Henne, Alexander V. Kuperman, Mark A. Dombroski, Michael A. LetavicVolume:
27
Year:
2006
Language:
english
Pages:
16
DOI:
10.1002/bdd.520
File:
PDF, 406 KB
english, 2006